CEBRX
Price
$9.51
Change
-$0.01 (-0.11%)
Updated
May 22 closing price
Net Assets
278.77M
MEDCX
Price
$11.91
Change
-$0.02 (-0.17%)
Updated
May 22 closing price
Net Assets
6.99B
Interact to see
Advertisement

CEBRX vs MEDCX

Header iconCEBRX vs MEDCX Comparison
Open Charts CEBRX vs MEDCXBanner chart's image
Columbia Emerging Markets Bond Inst2
Price$9.51
Change-$0.01 (-0.11%)
VolumeN/A
Net Assets278.77M
MFS Emerging Markets Debt C
Price$11.91
Change-$0.02 (-0.17%)
VolumeN/A
Net Assets6.99B
CEBRX vs MEDCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CEBRX vs. MEDCX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEBRX is a Hold and MEDCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MEDCX has more cash in the bank: 6.99B vs. CEBRX (279M). MEDCX (5.77) and CEBRX (5.54) have matching dividends . CEBRX was incepted earlier than MEDCX: CEBRX (13 years) vs MEDCX (23 years). MEDCX (1.82) is less costly to investors than CEBRX (0.75). MEDCX is a more actively managed with annual turnover of: 58.00 vs. CEBRX (41.00). CEBRX has a lower initial minimum investment than MEDCX: CEBRX (0) vs MEDCX (1000). CEBRX annual gain was more profitable for investors over the last year : 6.76 vs. MEDCX (5.43). CEBRX return over 5 years is better than : 13.76 vs. MEDCX (7.77).
CEBRXMEDCXCEBRX / MEDCX
Total Expense Ratio0.751.8141%
Annual Report Gross Expense Ratio0.751.8241%
Fund Existence13 years23 years-
Gain YTD2.4601.169210%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets279M6.99B4%
Annual Yield % from dividends5.545.7796%
Returns for 1 year6.765.43124%
Returns for 3 years19.5916.47119%
Returns for 5 years13.767.77177%
Returns for 10 years33.6221.43157%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OIGAX34.73N/A
N/A
Invesco Oppenheimer International Gr A
FICGX12.17N/A
N/A
Cantor Fitzgerald Large Cap Fcs Cl A
BMCRX24.67N/A
N/A
BlackRock Advantage Large Cap Gr R
TNVRX16.12N/A
N/A
1290 GAMCO Small/Mid Cap Value R
EMWLX17.34N/A
N/A
Lord Abbett Emerging Markets Equity R6